for Journals by Title or ISSN
for Articles by Keywords
  Medtech Insight
  [0 followers]  Follow
   Full-text available via subscription Subscription journal
   ISSN (Print) 1876-8008
   Published by Informa plc Homepage  [15 journals]
  • VADs Set To Enter Big Leagues With St. Jude's Plan To Acquire Thoratec
    • Abstract: St. Jude Medical says it will pay $3.4 billion to own ventricular-assist device leader Thoratec, pointing to significant synergies in the heart failure and interventional cardiology markets.
      PubDate: Wed, 26 Aug 2015 16:30:02 -040
  • PODCAST: A New Era In Stroke Care – An Interview With Medtronic's
           Brett Wall
    • Abstract: Positive data from five clinical trials and new treatment guidelines for mechanical thrombectomy devices have ushered in a new era in stroke care. In this first in a new series of podcasts, Medtech Insight spoke at the recent SNIS meeting with Brett Wall, vice president and president of the Neurovascular group at Medtronic, to find out what impact the trials and guidelines are having on stroke care, the market for mechanical thrombectomy devices, demand for Solitaire FR and the company's plans for innovation.
      PubDate: Tue, 25 Aug 2015 00:00:01 -040
  • Diabetes Market Sees Advances In CGMs, Artificial Pancreas Systems, And
    • Abstract: The focus of the diabetes market is firmly on the development of an artificial pancreas, now within two or three years from becoming commercialized, and progress is going so well that several companies are in line to release a product. Meanwhile, digital health is increasingly playing a major role in diabetes care, and device manufacturers are investing in connectivity solutions to satisfy patient and consumer needs.
      PubDate: Mon, 24 Aug 2015 09:00:00 -040
  • Cartilage Regeneration: Solving The Unsolvable'
    • Abstract: CartiHeal's simple, cell-free construct may offer a potential solution to one of the greatest unsolved problems in musculoskeletal surgery – cartilage regeneration. An interview with Nir Altschuler, founder and CEO of the Israeli start-up.
      PubDate: Thu, 20 Aug 2015 10:00:02 -040
  • Proteome Sciences Refines Assays For Early Alzheimer's Detection
    • Abstract: Proteome Sciences' diagnostic technologies are showing promise in detecting the onset of Alzheimer's disease earlier than any other method according to data from ongoing clinical trials presented at the recent Alzheimer’s Association International Conference (AAIC) in Washington, July 18-23.
      PubDate: Wed, 19 Aug 2015 08:00:00 -040
  • Helping The Blind To See: Medtech Start-Ups Focus On Vision Restoration
    • Abstract: In recent years, medtech start-ups have made great strides in developing technologies to treat eye disease such as cataracts, diminishing vision, and even dry eye. But the greatest leaps – or the most life changing – may have been executed by companies such as Second Sight Medical Products Inc. and Wicab Inc. that are finding ways to actually help blind people see.
      PubDate: Mon, 17 Aug 2015 10:30:02 -040
  • Ethicon Seeks To Expand Access To Bariatric Surgery, Increase Product
           Market Share Through Investment
    • Abstract: With nearly 30% of the world’s population overweight or obese, Johnson & Johnson's Ethicon division is seeking to expand patients’ access to bariatric surgery in certain countries by funding studies that demonstrate its benefits. By convincing payors in these countries that bariatric surgery addresses not only weight loss but also metabolic diseases, Ethicon hopes to increase its products' market share in these countries, too.
      PubDate: Fri, 14 Aug 2015 08:00:01 -040
  • Stroke Prevention For TAVR – And, Perhaps, Beyond
    • Abstract: Although TAVR-related stroke rates have been diminishing, it remains a devastating complication of the procedure. Two companies with devices to deflect or collect emboli are embarking on IDE trials that they hope will make cerebral embolic protection a standard of care in TAVR and perhaps other cardiac surgeries, as it already is in carotid artery stenting.
      PubDate: Thu, 13 Aug 2015 08:20:01 -040
  • Medical Device Deals Update, August 2015
    • Abstract: Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced June-July 2015.
      PubDate: Wed, 12 Aug 2015 09:00:01 -040
  • Medtech Execs On The Move, August 2015
    • Abstract: Recent executive-level company changes and promotions in the medical device and diagnostics industries.
      PubDate: Wed, 05 Aug 2015 12:00:01 -040
  • Intuitive Still Dominates, But New Robotic Surgery Players Could Speed
    • Abstract: Intuitive Surgical's latest earnings and procedure numbers beat analysts' expectations and further solidified its leading position in surgical robotics. But potential robotic rivals are in the wings with alternative solutions that could make robotic surgery more affordable and accessible, including Cambridge Medical Robotics, Transenterix, Titan Medical, SOFAR and J&J/Google.
      PubDate: Tue, 04 Aug 2015 09:00:01 -040
  • Philips' Lumify To Enable High-Quality Ultrasound Via Smart Device
    • Abstract: This fall, Royal Philips will make commercially available Lumify, an applications-based ultrasound solution that lets a physician use his own smart device, along with a Philips transducer, for convenient, high-quality, portable imaging that can be integrated into the patient’s hospital medical records.
      PubDate: Mon, 03 Aug 2015 15:00:01 -040
  • Medherant: Adhesive Patch For Transdermal Drug Delivery
    • Abstract: Medherant Ltd.'s drug delivery patch technology can accommodate medium or low potency drugs at a suitable saturation level to permeate the skin but without compromising adhesion, which existing patch technology has failed to achieve. This means that low potency drugs such as ibuprofen – the company's first product – can now be formulated into a patch rather than only being available in topical gel or cream.
      PubDate: Tue, 28 Jul 2015 09:00:01 -040
  • FDA Relies On Short-Term Data To Approve Medtronic's Recapturable TAVR
    • Abstract: The approval comes less than a week after FDA approved Edwards' Sapien 3 third-generation transcatheter aortic replacement valve. Both devices were approved based on short-term outcomes data instead of the two-year data FDA has required of TAVR systems in the past.
      PubDate: Tue, 14 Jul 2015 12:00:02 -040
  • A Device For Hypertension After All'
    • Abstract: Despite industry-wide contraction last year after Medtronic's SYMPLICITY, some believe a hypertension device is just around the corner. With a market estimated in the billions or even tens of billions of dollars, both Medtronic and Boston Scientific are launching redesigned studies, and a determined handful of medtech start-ups continue to pursue a device-based solution for treating hypertension with invasive and noninvasive approaches, including renal sympathetic denervation through radiofrequency, ultrasound, or drugs; neuromodulation in the forearm; and cold therapy to specialized cells in ...
      PubDate: Tue, 14 Jul 2015 00:05:01 -040
  • All Eyes On Ophthalmic Devices Market
    • Abstract: In the ophthalmic device sector, intraocular lens surgery is expanding way beyond the cataract market with paradigm shifting technology. The vast presbyopia market now has an FDA-approved "corneal inlay" option, micro invasive glaucoma surgery has created an entirely new device segment, and corneal cross-linking has the potential to transcend its role as an effective treatment for a corneal disease to possibly being the next big thing in the non-surgical treatment of refractive errors.
      PubDate: Tue, 14 Jul 2015 00:01:50 -040
  • BrainScope’s Head Injury Assessment Device Moves Closer To Military,
           Sports Use
    • Abstract: BrainScope received 510(k) clearance in May for Ahead 200, a second-generation, handheld, noninvasive device for the adjunctive assessment of traumatic brain injury in adults over 18 years of age. With an estimated 60 million cases of TBI annually worldwide, the company is initially focusing on military and sports applications, but is also looking at emerging markets such as India and China, where there are fewer CT scanners and the rate of head injury is substantially higher than in the US.
      PubDate: Tue, 14 Jul 2015 00:01:43 -040
  • Emerging PAD Devices Impress With New Trial Results, Funding
    • Abstract: Two very different ways to treat peripheral arterial disease – lithotripsy combined with angioplasty and nitinol Tack implants – have demonstrated impressive six-month and one-year clinical results, respectively, and companies with these devices continue to attract funding.
      PubDate: Tue, 14 Jul 2015 00:01:31 -040
  • First Minimally Invasive Vascular Access Technology Has Potential to
           Revolutionize Growing Hemodialysis Market
    • Abstract: With a projected worldwide market of over three million hemodialysis patients by 2020, TVA Medical Inc. sees a potential $1 billion+ annual market opportunity with everlinQ, a minimally invasive, catheter-based system that allows physicians to use an endovascular approach to create an arteriovenous fistula (AVF) for vascular access in chronic kidney patients who require ongoing hemodialysis.
      PubDate: Tue, 14 Jul 2015 00:01:22 -040
  • The Digital Health Care Revolution Picks Up Speed
    • Abstract: The excitement about digital health solutions has reached new heights as the market moves toward changes where those solutions are not only wanted, but in many cases needed to help battle costs and improve patient outcomes. The interest in digital health is part of a larger trend that is seeing patients take on more and more responsibility for their own health amid changing perceptions of what is considered a medical device.
      PubDate: Tue, 14 Jul 2015 00:01:04 -040
  • Innovation In The Age Of Breast-Conserving Surgery
    • Abstract: Medical device and diagnostic companies are developing innovative new products for women with breast cancer designed to facilitate earlier diagnosis, improve diagnostic accuracy, increase surgical precision, and enable the least invasive, most breast-conserving approach to breast cancer surgery. With the number of breast cancer cases in the US projected to increase dramatically by 2030, the success of these technologies depends on their ability to improve cosmetic results and survival rates while lowering overall health care costs.
      PubDate: Tue, 14 Jul 2015 00:00:55 -040
  • Philips' New Commercial Model Eschews Heavy Capital Investment
    • Abstract: Innovation is critical for medtech companies to stay ahead of the game and ensure continuous growth – but sometimes, this innovation does not necessarily have to come in the form of new technologies. Neil Mesher, managing director of Philips Healthcare UK & Ireland, tells Clinica how the company has developed a new ultrasound service – of which data analytics is a key enabler – that not only addresses fundamental challenges faced by mature health care systems, but also could potentially reinvigorate revenue stream.
      PubDate: Tue, 14 Jul 2015 00:00:49 -040
  • Reimbursement Unraveled: Will New French Medtech Innovation Plans Hit The
    • Abstract: Securing reimbursement for innovative medical devices in France calls for high levels of human and financial input. Yet the often cumbersome and misfiring adoption procedures deter manufacturers from approaching this ostensibly attractive medical device market – Europe’s second largest.
      PubDate: Tue, 14 Jul 2015 00:00:44 -040
  • MaRVis Medical: Guidewires For MRI-Guided Interventions
    • Abstract: The growing trend of using magnetic resonance imaging for enhanced visualization during medical interventions is being augmented by non-ferromagnetic guidewires that don't dislocate in the magnetic field; don't heat or conduct electricity, and don't create imaging artifacts that obscure or distort the target image. A portfolio of MR-safe guidewires from Germany-based MaRVis Medical GMBH fulfills these requisites by successfully integrating good mechanical and visualization properties.
      PubDate: Tue, 14 Jul 2015 00:00:39 -040
  • Harpoon Medical: Beating-Heart Mitral Valve Repair
    • Abstract: Harpoon Medical's Inc.'s beating heart mitral valve procedure uses an expanded polytetrafluorethylene anchor that replaces the non-functioning natural chordae tendineae. The anchor is inserted via a small incision between the ribs and into the leaflet to eliminate mitral valve regurgitation.
      PubDate: Tue, 14 Jul 2015 00:00:32 -040
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Tel: +00 44 (0)131 4513762
Fax: +00 44 (0)131 4513327
About JournalTOCs
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-2015